Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC

 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Anacor Pharmaceuticals, Inc. develops medical solutions.The firm operates as a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company was founded by Stephen J. Benkovic and Lucy... 
More about the company
Latest news on ANACOR PHARMACEUTICALS INC
2016 PFIZER : completes acquisition of Anacor Pharmaceuticals
2016 PFIZER : completes acquisition of Anacor
2016 ANACOR PHARMACEUTICALS, INC. : Completion of Acquisition or Disposition of Asset..
2016 ANACOR PHARMACEUTICALS, INC. : Amendments to Articles of Inc. or Bylaws; Change ..
2016 GLAXOSMITHKLINE PHARMACEUTICALS : How Wellcome, Gates profit from medical tech
2016DJJazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion
2016DJJazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion
2016 Anacor received rival bid before Pfizer deal - filing
2016 ACQUISITION OF ANACOR PHARMACEUTICAL : ANAC) Under Investigation for Investors
2016 Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Ana..
More news
Sector news : Biotechnology & Medical Research - NEC
03/28DJREGENERON PHARMACEUTICALS : FDA Approves Regeneron and Sanofi's Dupixent for Ecz..
03/28DJREGENERON PHARMACEUTICALS : FDA Approves Regeneron and Sanofi's Dupixent for Ecz..
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
03/17DJAMGEN : Money-Back Guarantee
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
01/24 We're Hesitant On AnaptysBio's IPO
01/18 MERGERS AND ACQUISITIONS IN 2016 : Pause For Breath In A Shifting Market
2016 New Oral Psoriasis Drug Tops Cellceutix Catalysts
2016 BIOTECH FORUM DAILY DIGEST : A Volatile Few Days, Some Small Caps Blow Up, Spotl..
2016 Novan's IPO - Buying A Dollar For Twenty Cents
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Paul L. Berns Chairman, President & Chief Executive Officer
Graeme Bell Chief Financial Officer & Executive Vice President
Jacob J. Plattner Senior Vice President-Research
Lee T. Zane Chief Medical Officer & Senior Vice President
Margaret M. Madden Secretary, Director & Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ANACOR PHARMACEUTICALS..0.00%0
INCYTE CORPORATION39.10%28 429
QUINTILES IMS HOLDINGS..3.48%18 567
LONZA GROUP AG3.12%10 618
CELLTRION, INC.--.--%9 982
SEATTLE GENETICS, INC.22.17%9 187
More Results